XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES    
Net income $ 9,915 $ 5,215
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 9,872 10,331
Inventory write-downs 1,893 1,609
Provision for bad debts - accounts receivable 251 64
Share-based compensation expense 2,905 3,523
Change in fair value of acquisition-related contingent liabilities 363 (442)
Change in fair value of written put options 653 (460)
Changes in assets and liabilities:    
Accounts receivable 3,891 9,650
Contract assets (1,671) 6,208
Inventories 2,241 18,280
Prepaid expenses and other current assets (1,292) 3,462
Other assets (959) (844)
Accounts payable and other current liabilities (4,292) 2,148
Payment of acquisition-related contingent liabilities (686) (279)
Long-term pension liability 325 561
Other long-term liabilities 1,088 362
Net cash provided by operating activities 24,497 59,388
CASH FLOWS FROM INVESTING ACTIVITIES    
Additions to property, plant and equipment (2,911) (4,023)
Net cash used in investing activities (2,911) (4,023)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from borrowings of debt 31,000 4,000
Repayment of debt (40,281) (51,813)
Debt issuance costs 0 (300)
Payment of cash dividends (6,994) (6,886)
Payment of acquisition-related contingent liabilities (897) (553)
Proceeds received on exercise of stock options 1,118 97
Common shares repurchased and retired (6,346) 0
Net cash used in financing activities (22,400) (55,455)
Effect of currency exchange rates on cash (709) 97
Net increase (decrease) in cash and cash equivalents (1,523) 7
Cash and cash equivalents balance, beginning of period 19,896 17,722
Cash and cash equivalents balance, end of period $ 18,373 $ 17,729